Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 9, 2013 - Issue 4
Submit an article Journal homepage
886
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome

Shilan MozaffariDepartment of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1417614411, [email protected]; [email protected]
,
Shekoufeh NikfarDepartment of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614411, Iran;Food & Drug Laboratory Research Center, Food and Drug Organization, Ministry of Health and Medical Education, Tehran 1314715311, Iran
&
Mohammad AbdollahiDepartment of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1417614411, [email protected]; [email protected]
Pages 403-421 | Published online: 19 Jan 2013

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Mohammad Hossein Asghari, Milad Moloudizargari, Haji Bahadar & Mohammad Abdollahi. (2017) A review of the protective effect of melatonin in pesticide-induced toxicity. Expert Opinion on Drug Metabolism & Toxicology 13:5, pages 545-554.
Read now
Shilan Mozaffari, Shekoufeh Nikfar & Mohammad Abdollahi. (2014) The safety of novel drugs used to treat irritable bowel syndrome. Expert Opinion on Drug Safety 13:5, pages 625-638.
Read now
Emanuel Raschi & Fabrizio De Ponti. (2014) Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome. Expert Opinion on Drug Metabolism & Toxicology 10:2, pages 293-305.
Read now

Articles from other publishers (10)

Natnicha Leelaviwat, Poemlarp Mekraksakit, Kristina M. Cross, Dylan M. Landis, Madison McLain, Laveena Sehgal & J. Drew Payne. (2022) Melatonin: Translation of Ongoing Studies Into Possible Therapeutic Applications Outside Sleep Disorders. Clinical Therapeutics 44:5, pages 783-812.
Crossref
Di Qin, Ling Yue, Bin Xue, Min Chen, Tai-Chun Tang & Hui Zheng. (2019) Pharmacological treatments for patients with irritable bowel syndrome. Medicine 98:32, pages e15920.
Crossref
Bartosz Kózka & Anna Kowalkowska. (2017) POCHODNE BENZIMIDAZOLU WYKAZUJĄCE AKTYWNOŚĆ BIOLOGICZNĄ. Prospects in Pharmaceutical Sciences 15:3, pages 16-33.
Crossref
Shannon M. Cearley, Supriya Immaneni & Padmini Shankar. (2017) Irritable Bowel Syndrome: The effect of FODMAPs and meditation on pain management. European Journal of Integrative Medicine 12, pages 117-121.
Crossref
Eduardo Esteban-Zubero, Laura López-Pingarrón, Moisés Alejandro Alatorre-Jiménez, Purificación Ochoa-Moneo, Celia Buisac-Ramón, Miguel Rivas-Jiménez, Silvia Castán-Ruiz, Ángel Antoñanzas-Lombarte, Dun-Xian Tan, José Joaquín García & Russel J. Reiter. (2017) Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. Life Sciences 170, pages 72-81.
Crossref
Arkadiusz Michalak, Paula Mosińska & Jakub Fichna. (2016) Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer. Frontiers in Pharmacology 7.
Crossref
Tai-Yi Hsu, Guan-Yi He, Yu-Chiao Wang, Chih-Yu Chen, Shih-Hao Wang, Wei-Kung Chen & Chia-Hung Kao. (2015) Alcohol Use Disorder Increases the Risk of Irritable Bowel Disease. Medicine 94:51, pages e2334.
Crossref
Seyed Reza Abtahi & Parvin Zareian. (2015) Assessment of Consensus-Based Pharmacological Therapies in Irritable Bowel Syndrome. Journal of Archives in Military Medicine 3:3.
Crossref
Rachel D. Moloney, Siobhain M. O’Mahony, Timothy G. Dinan & John F. Cryan. (2015) Stress-Induced Visceral Pain: Toward Animal Models of Irritable-Bowel Syndrome and Associated Comorbidities. Frontiers in Psychiatry 6.
Crossref
Tina Didari. (2015) Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology 21:10, pages 3072.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.